This web page is under construction..... please stay tuned.
Through 7 years of intense collaboration, HARMONY Alliance Partners, Associated Members and Associated Partners have successfully demonstrated the power of Big Data to improve the treatment of blood cancers. Here we plan to disclose a selection of our results and example cases. In the meantime please explore our New, Research Project, Data barometer and the Big Data Platform pages using the top navigation.
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
